| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/02/2004 | EP1372647A2 Use of substituted imidazo 1,2-a]-pyridine compounds as medicaments |
| 01/02/2004 | EP1372644A2 Use of substituted imidazo 1,2-a]-pyridine-3-yl-amide and imidazo 1,2-a]-pyridine-3-yl-amine compounds as medicaments |
| 01/02/2004 | EP1372643A1 Pyrazolopyridines, process for their preparation and use as therapeutic compounds |
| 01/02/2004 | EP1372642A1 Use of pyrazolopyridines as therapeutic compounds |
| 01/02/2004 | EP1372634A2 Fumaric acid amides |
| 01/02/2004 | EP1372627A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/02/2004 | EP1372626A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 01/02/2004 | EP1372605A2 Intravaginal drug delivery devices for the administration of an antimicrobial agent |
| 01/02/2004 | EP1372603A1 Topical application for treating toenail fungus |
| 01/02/2004 | EP1372571A2 Method and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds |
| 01/02/2004 | EP1372528A2 Mucosal boosting following parenteral priming |
| 01/02/2004 | EP1372394A1 Antifungal composition with enhanced bioavailability |
| 01/02/2004 | EP1372389A2 Virucidal compositions |
| 01/02/2004 | EP1372383A2 Antimicrobial formulations |
| 01/02/2004 | EP0986570B9 Gemcitabine derivatives |
| 01/02/2004 | EP0831921B1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 01/02/2004 | EP0719343B1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 01/02/2004 | EP0705109B2 Adjuvants for vaccines against respiratory syncytial virus |
| 01/01/2004 | US20040002613 Synthesis of benzonitriles from substituted benzoic acid |
| 01/01/2004 | US20040002608 Central nervous system disorders |
| 01/01/2004 | US20040002602 Synthetic process for the manufacture of an ecteinaschidin compound |
| 01/01/2004 | US20040002585 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 01/01/2004 | US20040002581 Peptides and use thereof in therapeutic agents against HIV infection |
| 01/01/2004 | US20040002540 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 01/01/2004 | US20040002533 Culture product of Streptomyces; lanosterol synthase inhibitor; anticholesterol agents, fungicides |
| 01/01/2004 | US20040002525 Obesity; osteoporosis |
| 01/01/2004 | US20040002521 Antiinflammatory agents; metalloprotease inhibitor; antiarthritic agents; antiallergens; viricides |
| 01/01/2004 | US20040002511 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators |
| 01/01/2004 | US20040002498 Tricyclic compounds useful as HIV reverse transcriptase inhibitors |
| 01/01/2004 | US20040002496 Compositions useful as inhibitors of protein kinases |
| 01/01/2004 | US20040002485 Enzyme inhibitors; viricides |
| 01/01/2004 | US20040002482 Androgen pharmaceutical composition and method for treating depression |
| 01/01/2004 | US20040002481 Novel 4-dedimethylaminotetracycline derivatives |
| 01/01/2004 | US20040002476 Modified fluorinated nucleoside analogues |
| 01/01/2004 | US20040002464 11-C-substituted ketolides |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002066 36 human secreted proteins |
| 01/01/2004 | US20040001898 Fermentated dietetic fibers; anticancer agents |
| 01/01/2004 | US20040001867 Vectors for molecule delivery to CD11b expressing cells |
| 01/01/2004 | US20040001864 Using antigens; genetic enginering; gene expression of capsid; heat resistance |
| 01/01/2004 | US20040001854 Isolated, genetic engineered polypeptide |
| 01/01/2004 | US20040001853 Genetic engineering; immunoglobulins; hepatitis virus ; induce immunology response |
| 01/01/2004 | US20040001850 Dna sequences; genetic engineering |
| 01/01/2004 | US20040001836 Mixture of polypeptide with carrier |
| 01/01/2004 | US20040001824 Cell proliferation inhibitors |
| 01/01/2004 | US20040001818 Prevention endothelial cell migration; antiproliferative agent; diaphorase inhibitor |
| 12/31/2003 | WO2004001022A1 Probiotic propionibacterium jensenii 702 |
| 12/31/2003 | WO2004000887A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 12/31/2003 | WO2004000873A2 Adjuvant-free peptide vaccine |
| 12/31/2003 | WO2004000865A1 Pharmaceutical compositions of azithromycin |
| 12/31/2003 | WO2004000864A2 11-c-substituted ketolides |
| 12/31/2003 | WO2004000858A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 12/31/2003 | WO2004000854A1 Sulfur-containing phospholipid derivatives |
| 12/31/2003 | WO2004000846A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 12/31/2003 | WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 12/31/2003 | WO2004000372A2 Disinfecting composition, cleaning tablet produced therefrom, and use thereof |
| 12/31/2003 | WO2004000368A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 12/31/2003 | WO2004000365A1 Drug transport and delivery system |
| 12/31/2003 | WO2004000360A1 Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis |
| 12/31/2003 | WO2004000359A1 Topical pharmaceutical composition comprising skin penetration enhancers for the treatment of warts |
| 12/31/2003 | WO2004000339A1 Honey-based skin care preparation |
| 12/31/2003 | WO2004000333A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 12/31/2003 | WO2004000330A1 Use of amphiphilic nucleoside phosphonoformic acid derivatives for the treatment of viral infectious diseases |
| 12/31/2003 | WO2004000323A1 Medicinal cephem compound composition for injection |
| 12/31/2003 | WO2004000320A1 Water-based preparation for eye drop |
| 12/31/2003 | WO2004000310A1 Medicament for the treatment of the systemic inflammatory response syndrome |
| 12/31/2003 | WO2004000298A1 Pharmaceutical compositions for the treatment of infections of the respiratory system by pathogenic agents |
| 12/31/2003 | WO2004000271A1 Use of bases for the manufacture of a medicament in the treatment of different forms of inflammatory dermatosis |
| 12/31/2003 | WO2004000245A1 Promoter for uptake of basic amino acid into cell and cosmetic or drug composition |
| 12/31/2003 | WO2004000228A2 Methods for preventing and treating microbial infections by modulating transcription factors |
| 12/31/2003 | WO2004000226A2 Liposomes containing biologically active compounds |
| 12/31/2003 | WO2004000116A1 Devices and methodologies useful in body aesthetics |
| 12/31/2003 | WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 12/31/2003 | WO2004000025A1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes |
| 12/31/2003 | WO2004000016A2 Antimicrobial compositions, products and methods employing same |
| 12/31/2003 | WO2003094911B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 12/31/2003 | WO2003084568A3 Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations |
| 12/31/2003 | WO2003077832A3 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 12/31/2003 | WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/31/2003 | WO2003072576A3 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 12/31/2003 | WO2003066586A3 Purine and isosteric antibacterial compounds |
| 12/31/2003 | WO2003065991A3 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 12/31/2003 | WO2003059269A3 Acridone inhibitors of impdh enzyme |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2003052138A3 Methods of detecting modification of genetic material |
| 12/31/2003 | WO2003049746A3 Combination of cytochome p450 dependent protease inhibitors |
| 12/31/2003 | WO2003035058A3 Polymaleide compounds and their medical use |
| 12/31/2003 | WO2003035004A9 Immunotherapy for reversing immune suppression |
| 12/31/2003 | WO2003022879B1 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them |
| 12/31/2003 | WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/31/2003 | WO2003006492A3 Biologically active peptides |
| 12/31/2003 | WO2002077648A3 Pathogenic and commensal vaccine antigens |
| 12/31/2003 | WO2002070562A3 Nuclear hormone receptor ligand binding domain |
| 12/31/2003 | WO2002070004A3 Papillomavirus vaccines |
| 12/31/2003 | WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 12/31/2003 | WO2002047708A3 Selective cox-2 inhibition from edible plant extracts |
| 12/31/2003 | WO2002047615A3 Oral compositions and use thereof |
| 12/31/2003 | WO2002042444A3 Fungal gene cluster associated with pathogenesis |
| 12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
| 12/31/2003 | CN1464880A New macrolides with antibacterial activity |